Antiemetic Effect of Rikkunshito, a Japanese Kampo Herbal Medicine, on Cisplatin-induced Nausea And Vomiting: A Nationwide Database Study In Japan.

Kampo Rikkunshito antiemetics cancer chemotherapy real-world

Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
26 Jul 2023
Historique:
medline: 27 7 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: aheadofprint

Résumé

Objective The effect of Rikkunshito, a Japanese herbal Kampo medicine, on chemotherapy-induced nausea and vomiting (CINV) has been evaluated in several small prospective studies, with mixed results. We retrospectively evaluated the antiemetic effects of Rikkunshito in patients undergoing cisplatin-based chemotherapy using a large-scale database in Japan. Methods The Diagnosis Procedure Combination inpatient database from July 2010 to March 2019 was used to compare adult patients with malignant tumors who had received Rikkunshito on or before the day of cisplatin administration (Rikkunshito group) and those who had not (control group). Antiemetics on days 2 and 3 and days 4 and beyond following cisplatin administration were used as surrogate outcomes for CINV. Patient backgrounds were adjusted using the stabilized inverse probability of treatment weighting, and outcomes were compared using univariable regression models. Results We identified 669 and 123,378 patients in the Rikkunshito and control groups, respectively. There were significantly fewer patients using intravenous 5-HT

Identifiants

pubmed: 37495535
doi: 10.2169/internalmedicine.1946-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Taisuke Jo (T)

Department of Health Services Research, The University of Tokyo, Japan.
Department of Respiratory Medicine, The University of Tokyo, Japan.

Daisuke Shigemi (D)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.

Takaaki Konishi (T)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.
Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Japan.

Hayato Yamana (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.
Data Science Center, Jichi Medical University, Japan.

Nobuaki Michihata (N)

Department of Health Services Research, The University of Tokyo, Japan.

Ryosuke Kumazawa (R)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.
Center for Clinical Sciences, National Center for Global Health and Medicine, Japan.

Akira Yokoyama (A)

Department of Respiratory Medicine, The University of Tokyo, Japan.

Hirokazu Urushiyama (H)

Department of Respiratory Medicine, The University of Tokyo, Japan.

Hiroki Matsui (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.

Kiyohide Fushimi (K)

Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, Japan.

Takahide Nagase (T)

Department of Respiratory Medicine, The University of Tokyo, Japan.

Hideo Yasunaga (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan.

Classifications MeSH